Phototherapy (as needed)

OTHER2 trials

Sponsors

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

Conditions

Hyperbilirubinemia, NeonatalJaundiceNeonatal Hyperbilirubinemia

Phase 2

A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia

TerminatedNCT00850993

InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyHyperbilirubinemia, Neonatal

Start: 2008-08-31End: 2012-05-31Updated: 2019-10-30

Unknown Phase

Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)

CompletedNCT02033096

InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyJaundice, Neonatal Hyperbilirubinemia

Start: 2008-10-20End: 2015-11-09Updated: 2019-10-15